Albert Dahan, Jack D C Dahan, Erik Olofsen, Maarten Van Lemmen, Monique Van Velzen, Elise Sarton, George Dungan, Thomas L Miller, Robert B Raffa, Chris Martini, Marieke Niesters
The proposed model quantitatively links two pharmacodynamic consequences of competitive μ-opioid receptor antagonism and generates testable hypotheses regarding the receptor activation threshold underlying precipitated withdrawal. The presented utility function is an experimental modeling exercise. In life-threatening opioid overdoses, restoration of ventilation, prevention of hypoxic injury and survival take priority over avoidance of withdrawal (i.e., set k < 1).
BACKGROUND: Naloxone reverses opioid-induced respiratory depression (RD) but may precipitate withdrawal in opioid-dependent individuals. Although both have been studied separately, their concentration-response relationships have not been described within a single model. We developed a mechanistic pharmacokinetic/pharmacodynamic simulation model combining an established model of naloxone-induced reversal of fentanyl-induced RD with a novel mechanistic model of precipitated withdrawal based on normalized μ-opioid receptor activation.
METHODS: Utility was defined as the probability (P) of respiratory reversal minus the weighted probability of precipitated withdrawal, P(reversal) - k·P(withdrawal), where k denotes the relative weight assigned to withdrawal. A withdrawal threshold parameter w was introduced to reflect the fractional decrease in μ-opioid receptor activation required to precipitate withdrawal. w was calibrated using published naloxone-withdrawal data. Simulations allowed evaluations across varying naloxone concentrations, overdose severities, withdrawal thresholds and weighting factors.
RESULTS: The model reproduced the expected concentration-response relationships for respiratory depression, withdrawal, and their combined utility. Utility increased with higher withdrawal thresholds and decreased with greater withdrawal weight. Calibration against clinical data yielded a preliminary w estimate = 0.30 (95%CI 0.16-0.40). At this value of w at k = 1 (a neutral model reference of equal weight to reversal and withdrawal), the utility was negative over the naloxone concentration range of 10-30 ng/mL, indicating that modeled probability of precipitated withdrawal exceeded that of model-defined respiratory reversal over this range. At k < 1, the utility became positive.
CONCLUSION: The proposed model quantitatively links two pharmacodynamic consequences of competitive μ-opioid receptor antagonism and generates testable hypotheses regarding the receptor activation threshold underlying precipitated withdrawal. The presented utility function is an experimental modeling exercise. In life-threatening opioid overdoses, restoration of ventilation, prevention of hypoxic injury and survival take priority over avoidance of withdrawal (i.e., set k < 1).